Tested Applications
| Positive IHC detected in | human liver cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF/ICC detected in | HepG2 cells, HEK-293 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
12749-1-AP targets ADAMTS1 in WB, IHC, IF/ICC, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human, mouse, rat |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag3485 Product name: Recombinant human ADAMTS1 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 253-546 aa of BC036515 Sequence: FVSSHRYVETMLVADQSMAEFHGSGLKHYLLTLFSVAARLYKHPSIRNSVSLVVVKILVIHDEQKGPEVTSNAALTLRNFCNWQKQHNPPSDRDAEHYDTAILFTRQDLCGSQTCDTLGMADVGTVCDPSRSCSVIEDDGLQAAFTTAHELGHVFNMPHDDAKQCASLNGVNQDSHMMASMLSNLDHSQPWSPCSAYMITSFLDNGHGECLMDKPQNPIQLPGDLPGTSYDANRQCQFTFGEDSKHCPDAASTCSTLWCTGTSGGVLVCQTKHFPWADGTSCGEGKWCINGKCV Predict reactive species |
| Full Name | ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
| Calculated Molecular Weight | 967 aa, 105 kDa |
| GenBank Accession Number | BC036515 |
| Gene Symbol | ADAMTS1 |
| Gene ID (NCBI) | 9510 |
| RRID | AB_2877879 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9UHI8 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for ADAMTS1 antibody 12749-1-AP | Download protocol |
| IHC protocol for ADAMTS1 antibody 12749-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
Anti-ADAMTS1 (Cat# 12749-1-AP) has 8 citations across journals including NPJ Precision Oncology, Atherosclerosis, Life Sciences, Cell Biology and Toxicology, Frontiers in Aging Neuroscience, Journal of Molecular and Cellular Cardiology, JOR Spine, and Frontiers in Genetics. Research fields span salivary duct carcinoma, vascular calcification, cardiac fibrosis, Alzheimer's disease, congenital aortic stenosis, intervertebral disc degeneration, and metabolic dysfunction-associated fatty liver disease.
| Species | Application | Title |
|---|---|---|
NPJ Precis Oncol Identification of novel prognostic and predictive biomarkers in salivary duct carcinoma via comprehensive molecular profiling | ||
Atherosclerosis Loss of ADAMTS5 promotes vascular calcification via versican/integrin β1/FAK signal
| ||
Life Sci The matrix protease ADAMTS1 is transcriptionally activated by KLF6 and contributes to cardiac fibrosis in non-ischemic cardiomyopathy | ||
Cell Biol Toxicol Targeting ADAMTS1/HDAC6 alleviates TGF-β1/SMAD2-associated cardiac fibrosis in cardiac fibrosis post-myocardial infarction. | ||
Front Aging Neurosci Induction of A Disintegrin and Metalloproteinase with Thrombospondin motifs 1 by a rare variant or cognitive activities reduces hippocampal amyloid-β and consequent Alzheimer's disease risk | ||
J Mol Cell Cardiol Deficiency of Sox7 leads to congenital aortic stenosis via abnormal valve remodeling |







